Philip Lavin

Boston Biostatistical Research Foundation

3 Cahill Drive

Framingham, MA 01702

United States

SCHOLARLY PAPERS

2

DOWNLOADS
Rank 5,802

SSRN RANKINGS

Top 5,802

in Total Papers Downloads

10,693

SSRN CITATIONS

2

CROSSREF CITATIONS

0

Scholarly Papers (2)

VIP in the Treatment of Critical COVID-19 With Respiratory Failure in Patients With Severe Comorbidity: A Prospective Externally-Controlled Trial

Number of pages: 13 Posted: 04 Aug 2020 Last Revised: 05 Oct 2021
Houston Methodist Research Institute, Johns Hopkins School of Medicine, Boston Biostatistical Research Foundation, Houston Methodist Hospital, Houston Methodist Hospital, Houston Methodist Hospital, Houston Methodist Hospital, Houston Methodist Hospital and Houston Methodist Hospital
Downloads 6,813 (1,475)

Abstract:

Loading...

VIP, Zyesami, vasoactive intestinal peptide, aviptadil, SARS-CoV-2, corona virus, COVID-19, respiratory failure, IL6, ARDS

2.

Intravenous Aviptadil Is Associated with Increased Recovery and Survival in Patients with COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial

Number of pages: 17 Posted: 11 May 2021 Last Revised: 22 Aug 2021
Houston Methodist Research Institute, University of California, Irvine, Johns Hopkins School of Medicine, Boston Biostatistical Research Foundation, University of Louisville School of Medicine, Providence St. Jude Medical Center/St. Joseph Health Care, Medical Director, Critical Care, Oregon Clinic and University of Miami - Miller School of Medicine
Downloads 3,880 (3,892)
Citation 1

Abstract:

Loading...

Aviptadil, COVID-19, Respiratory Failure, VIP, Vasoactive Intestinal Peptide, ZYESAMI